ES8402585A1 - Procedimiento para la preparacion de nuevas benzoxazin-2-onas. - Google Patents

Procedimiento para la preparacion de nuevas benzoxazin-2-onas.

Info

Publication number
ES8402585A1
ES8402585A1 ES522104A ES522104A ES8402585A1 ES 8402585 A1 ES8402585 A1 ES 8402585A1 ES 522104 A ES522104 A ES 522104A ES 522104 A ES522104 A ES 522104A ES 8402585 A1 ES8402585 A1 ES 8402585A1
Authority
ES
Spain
Prior art keywords
compounds
group
benzoxazin
ones
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522104A
Other languages
English (en)
Other versions
ES522104A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES8402585A1 publication Critical patent/ES8402585A1/es
Publication of ES522104A0 publication Critical patent/ES522104A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE NUEVAS BENZOXAZIN-2-ONAS.CONSISTE EN HACER REACCIONAR UN COMPUESTO HIDROXILICO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III) EN PRESENCIA DE UN DISOLVENTE COMO METANOL, O DE UN AGENTE ANHIDRO COMO ACETONA O DE UNA BASE ALCALINA COMO HIDROXIDO SODIDO, A TEMPERATURA ENTRE 0J Y 100J, PARA OBTENER UN COMPUESTO DE FORMULA (I); R2 Y R3 PUEDEN SER IGUALES O DIFERENTES, SIGNIFICAN ATOMOS DE HIDROGENO, GRUPO FENILO, GRUPO ALCOHILO DE C1 A 6; R4 SIGNIFICA UN ATOMO DE HIDROGENO; R6 SIGNIFICA, UN ATOMO DE HIDROGENO O HALOGENO, O UNGRUPO ALCOHILO DE C1 A 3; R1 SIGNIFICA UN GRUPO ALCOHILO DE C1 A 3, O GRUPO FENILO; A SIGNIFICA UN ATOMO DE AZUFRE, UN GRUPO DE SO2; D SIGNIFICA UN GRUPO ALCOHILENO DE CADENA RECTA DE C2 A 6.SE UTILIZAN COMO MEDICAMENTOS POR SUS PROPIEDADES ANTITROMBOTICAS.
ES522104A 1982-05-06 1983-05-05 Procedimiento para la preparacion de nuevas benzoxazin-2-onas. Granted ES522104A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823217012 DE3217012A1 (de) 1982-05-06 1982-05-06 Benzoxazin-2-one, deren herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
ES8402585A1 true ES8402585A1 (es) 1984-02-01
ES522104A0 ES522104A0 (es) 1984-02-01

Family

ID=6162917

Family Applications (3)

Application Number Title Priority Date Filing Date
ES522104A Granted ES522104A0 (es) 1982-05-06 1983-05-05 Procedimiento para la preparacion de nuevas benzoxazin-2-onas.
ES526723A Expired ES8406453A1 (es) 1982-05-06 1983-10-25 Procedimiento para la preparacion de nuevas benzoxazin-2-onas
ES526724A Granted ES526724A0 (es) 1982-05-06 1983-10-25 Procedimiento para la preparacion de nuevas benzoxazin-2-onas

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES526723A Expired ES8406453A1 (es) 1982-05-06 1983-10-25 Procedimiento para la preparacion de nuevas benzoxazin-2-onas
ES526724A Granted ES526724A0 (es) 1982-05-06 1983-10-25 Procedimiento para la preparacion de nuevas benzoxazin-2-onas

Country Status (25)

Country Link
US (1) US4518597A (es)
EP (1) EP0093922B1 (es)
JP (1) JPS58203979A (es)
KR (1) KR900006546B1 (es)
AT (1) ATE24501T1 (es)
AU (1) AU563453B2 (es)
CA (1) CA1204744A (es)
CS (1) CS236876B2 (es)
DD (1) DD210453A5 (es)
DE (2) DE3217012A1 (es)
DK (1) DK164860C (es)
ES (3) ES522104A0 (es)
FI (1) FI79704C (es)
GB (1) GB2119382B (es)
GR (1) GR79255B (es)
HU (1) HU194842B (es)
IE (1) IE55481B1 (es)
IL (1) IL68573A (es)
NO (1) NO158738C (es)
NZ (1) NZ204143A (es)
PL (1) PL139119B1 (es)
PT (1) PT76627B (es)
SU (1) SU1138025A3 (es)
YU (1) YU42854B (es)
ZA (1) ZA833190B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3439281A1 (de) * 1984-10-26 1986-04-30 Bayer Ag, 5090 Leverkusen Chromogene 4,4-diaryl-2-oxo-benzo-3,1-oxazine, ihre herstellung und verwendung
US5519021A (en) * 1992-08-07 1996-05-21 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
IL106507A (en) * 1992-08-07 1997-11-20 Merck & Co Inc Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type
US5874430A (en) * 1996-10-02 1999-02-23 Dupont Pharmaceuticals Company 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
US5965729A (en) 1997-02-05 1999-10-12 Merck & Co., Inc. Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
US6509334B1 (en) * 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
EP2247579B1 (en) * 2008-01-17 2012-04-18 Bayer Pharma Aktiengesellschaft Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments
EP3102567B1 (en) 2014-02-04 2019-07-17 University of Tennessee Research Foundation Inhibitors of paxillin function and related compositions and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3526621A (en) * 1966-08-03 1970-09-01 Farmaceutical Italia Soc Substituted 3,1-benzoxazin-2-one
US3542774A (en) * 1968-07-05 1970-11-24 Warner Lambert Pharmaceutical 3,4-dihydrobenzoxazinones
CH624395A5 (es) * 1976-01-08 1981-07-31 Ciba Geigy Ag
SU843739A3 (ru) * 1978-02-17 1981-06-30 Карл Томэ Гмбх (Фирма) Способ получени карбостириловыхили ОКСиНдОлОВыХ пРОизВОдНыХ
US4442111A (en) * 1981-07-25 1984-04-10 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Antithrombotic sulfimino and sulfoximino indolinones-2

Also Published As

Publication number Publication date
EP0093922A2 (de) 1983-11-16
DE3368621D1 (en) 1987-02-05
GR79255B (es) 1984-10-22
IE55481B1 (en) 1990-09-26
EP0093922B1 (de) 1986-12-30
PT76627B (de) 1986-02-26
NO158738B (no) 1988-07-18
GB8312344D0 (en) 1983-06-08
FI831412L (fi) 1983-11-07
DK164860B (da) 1992-08-31
NO831599L (no) 1983-11-07
GB2119382A (en) 1983-11-16
ES522104A0 (es) 1984-02-01
FI79704B (fi) 1989-10-31
NZ204143A (en) 1986-02-21
CA1204744A (en) 1986-05-20
IE831032L (en) 1983-11-06
FI79704C (fi) 1990-02-12
DD210453A5 (de) 1984-06-13
KR840004736A (ko) 1984-10-24
ES8406454A1 (es) 1984-07-01
DK164860C (da) 1993-01-11
CS236876B2 (en) 1985-05-15
ES526724A0 (es) 1984-07-01
AU563453B2 (en) 1987-07-09
ES526723A0 (es) 1984-07-01
FI831412A0 (fi) 1983-04-26
PL241806A1 (en) 1984-08-13
JPS58203979A (ja) 1983-11-28
PT76627A (de) 1983-06-01
ES8406453A1 (es) 1984-07-01
NO158738C (no) 1988-11-16
DK195583D0 (da) 1983-05-03
PL139119B1 (en) 1986-12-31
IL68573A0 (en) 1983-09-30
ZA833190B (en) 1985-01-30
KR900006546B1 (ko) 1990-09-13
US4518597A (en) 1985-05-21
AU1426583A (en) 1983-11-10
YU42854B (en) 1988-12-31
DE3217012A1 (de) 1983-11-10
DK195583A (da) 1983-11-07
SU1138025A3 (ru) 1985-01-30
YU95783A (en) 1985-10-31
ATE24501T1 (de) 1987-01-15
GB2119382B (en) 1985-09-18
IL68573A (en) 1986-10-31
EP0093922A3 (en) 1984-01-25
HU194842B (en) 1988-03-28

Similar Documents

Publication Publication Date Title
ES8303395A1 (es) "procedimiento de preparar compuestos benzoxepinicos y analogos".
DE10399014I1 (de) Aminderivate Verfahren zu ihrer Herstellung und diese enthaltende Fungizide
ES8406453A1 (es) Procedimiento para la preparacion de nuevas benzoxazin-2-onas
ES8403437A1 (es) Un procedimiento para obtener derivados de indanilbenzamida.
ES463234A1 (es) Procedimiento para preparar compuestos de aril azufre.
ES527739A0 (es) Un procedimiento para preparar derivados de pirimidina
ES8107168A1 (es) Procedimiento para preparar derivados bencilidenicos en for-ma sin, anti o mezcla sin-anti